Private Wealth Management Group’s Arbutus Biopharma ABUS Stock Holding History

Private Wealth Management Group’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16K	Hold	242	–	–	﹤0.01%	1272
2026 Q1	$1.09K	Hold	242	–	–	﹤0.01%	1237
2025 Q4	$1.17K	Hold	242	–	–	﹤0.01%	1228
2025 Q3	$1.1K	Hold	242	–	–	﹤0.01%	1260
2025 Q2	$748	Hold	242	–	–	﹤0.01%	1340
2025 Q1	$845	Hold	242	–	–	﹤0.01%	1306
2024 Q4	$792	Hold	242	–	–	﹤0.01%	1351
2024 Q3	$932	Hold	242	–	–	﹤0.01%	1304
2024 Q2	$748	Hold	242	–	–	﹤0.01%	1354
2024 Q1	$625	Hold	242	–	–	﹤0.01%	1395
2023 Q4	$605	Buy	+242	New	+$474	﹤0.01%	1423

Other funds holding ABUS

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Private Wealth Management Group's ABUS Position: Q2 2026 in Review

Private Wealth Management Group held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 242 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Private Wealth Management Group first reported a position in ABUS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17K in Q4 2025. 177 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

Private Wealth Management Group held 242 shares of Arbutus Biopharma worth $1.16K as of Q2 2026.
Private Wealth Management Group left its Arbutus Biopharma share count unchanged in Q2 2026.
Arbutus Biopharma made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #1272 holding.
Private Wealth Management Group first reported a position in Arbutus Biopharma in Q4 2023 and has held it in 11 quarters since.
Private Wealth Management Group's Arbutus Biopharma position peaked at $1.17K in Q4 2025.
177 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.